Otsuka Pharmaceutical Co., Ltd. v. JAMP Pharma Corporation
2023
T-1737-23
Pending
8.2 PMNOC
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,832,157 (brexpiprazole).
Counsel to:
JAMP Pharma Corporation
The decision is reported
here.
Meet the team

Warren Sprigings
Partner

Meghan A. Dureen, Ph.D.
Counsel

Alexandre Lavoie
Associate

Raenaud Tiwari
Associate